Skip to main content
. 2017 May 31;16(1):499–506. doi: 10.3892/mmr.2017.6660

Figure 3.

Figure 3.

Decreased expression of SOX7 predicts poor prognosis in patients with liver cancer. The Kaplan-Meier method was used to evaluate the difference in (A) patient overall survival, (B) patient overall BCR (disease-free) survival, (C) non-metastatic patient survival and (D) non-metastatic patient BCR (disease-free) survival between the patients with high and low expression levels of SOX7. The mean of the SOX7 high-throughput sequencing mRNA expression levels in liver cancer tissues from the TCGA dataset was used as the cut-off to divide the liver cancer tissues from each patient into the high and low SOX7 expression groups. SOX7, sex determining region Y-box 7; BCR, biochemical recurrence.